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Abstract
Severe burn injury remains a major burden on patients and
healthcare systems. Following severe burns, the injured tissues
mount a local inflammatory response aiming to restore homeo-
stasis. With excessive burn load, the immune response becomes
disproportionate and patients may develop an overshooting sys-
temic inflammatory response, compromising multiple physiological
barriers in the lung, kidney, liver, and brain. If the blood–brain
barrier is breached, systemic inflammatory molecules and phago-
cytes readily enter the brain and activate sessile cells of the central
nervous system. Copious amounts of reactive oxygen species,
reactive nitrogen species, proteases, cytokines/chemokines, and
complement proteins are being released by these inflammatory
cells, resulting in additional neuronal damage and life-threatening
cerebral edema. Despite the correlation between cerebral
complications in severe burn victims with mortality, burn-induced
neuroinflammation continues to fly under the radar as an
underestimated entity in the critically ill burn patient. In this paper,
we illustrate the molecular events leading to blood–brain barrier
breakdown, with a focus on the subsequent neuroinflammatory
changes leading to cerebral edema in patients with severe burns.
Introduction
Severe burn injury remains a significant health issue for
society and a life-threatening event for the victim. Each year,
more than 1.2 million people in the United States alone suffer
burn injuries [1]; some 100,000 of these patients are
hospitalized, accounting for a total of 2 million hospital days
[2]. Thermal injuries mainly affect patients younger than
50 years of age [3] and remain one of the leading causes of
childhood deaths, according to the Children’s Burn Aware-
ness Program. While the overall mortality has been reported
to be 5%, it rapidly increases with advancing age and burn
size up to 96% [3]. Most fatalities (65%) seem to be linked to
burn-induced multiple organ failure, and 93% of burn patients
present with clinical signs of the systemic inflammatory
response syndrome before succumbing to their injuries [4].
One of the critically impaired yet frequently overlooked
organs in severe burn victims is the brain, despite the fact
that cerebral complications in severe burn victims have been
shown to highly correlate with mortality [5]. Hypoxic brain
injury has been found as a primary cause of death in up to
10% of severe burn patients in an age-dependent manner
[6]. The present review focuses on the neuroinflammatory
changes occurring after severe burn injury and on the
molecular mechanisms involved in their pathogenesis.
Breakdown of the blood–brain barrier and
development of cerebral edema
Under physiological conditions, the blood–brain barrier (BBB)
tightly regulates the molecules that enter the brain tissue.
During the systemic inflammatory response syndrome, sepsis,
or severe burn injury, however, this physical barrier between
the systemic circulation and the cerebral parenchyma can be
seriously compromised.
When peripheral tissues are exposed to severe burns, they
release a plethora of proinflammatory mediators, cytotoxic
proteases, reactive nitrogen species, and reactive oxygen
species. These mediators then cause systemic reactions, such
as fever [7,8], hypogeusia [9], hyperalgesia [10,11], severe
burn-induced anorexia (wasting syndrome) [9,12], hormonal
alterations of the hypothalamic–pituitary–adrenal axis, and
changes of endogenous catecholamine levels [13,14]. All of
these inflammatory changes attempt to restore equilibrium in
the body. When the burn load is overwhelming, however, the
systemic levels of released inflammatory mediators become
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excessive and disproportionate with deleterious outcome [15].
The cerebral microvascular permeability is increased and
enables previously blocked, large systemic molecules, such as
albumin (Figure 1a), exudates, and numerous inflammatory
cells to leak into the surrounding brain tissue.
These events cause subsequent neuronal damage [16] and
cerebral edema [17,18], and can result in critically increased
intracranial pressure [19]. The pathophysiological events
leading to this severe inflammatory downward spiral are
depicted in Figure 2. The extent of BBB leakage following
severe burn seems to correlate with mortality in severe burn
victims [5]. In the following sections, we illustrate the
molecular mechanisms involved in BBB failure.
Subcellular immunological changes
Complement activation
Activation of the complement system has been described
following severe burns in experimental as well as patient
settings [20,21]. While beneficial in moderation, overshooting
activation of complement can become harmful to the host. In
fact, experimental burn trauma-induced secondary injury to
the lungs [20] and burn-induced generation of the
anaphylatoxin C5a could be linked to cardiac dysfunction,
represented by significant reduction of left ventricular
pressures and impaired sarcomere contractility [22]. In
addition, robust complement activation has been described
as a key event in the neuropathophysiology of traumatic brain
injury and meningitis [23].
Surprisingly, there is extremely limited literature on the role of
the complement system in neuroinflammation following burns.
It seems reasonable, however, to assume that the comple-
ment cascade plays an important role in the pathophysiology
of burn-induced neuroinflammation, since components of the
complement system are being expressed and released by
multiple sessile cerebral cell types.
In our laboratory, we found evidence of burn-induced modu-
lation of the two C5a receptors (C5aR and C5L2) following a
standardized rat model of full-thickness scald injury, in which
30% of the total body surface area is burnt. We compared
Figure 1
Blood–brain barrier breakdown and complement C5a receptor expression in experimental burn injury. (a) Coronal sections of rat brains obtained
as a function of time after experimental burn injury. Sections were then subjected to immunohistochemical staining for albumin. In the control slide,
the primary antibody was omitted (no Ab) to ensure specific staining of the albumin antibody. Brain slides from sham animals (sham) were
compared with brains obtained from burned rats. Note the progressive breakdown of the blood–brain barrier from 6 to 24 hours after burn injury
resulting in increased cerebral accumulation of albumin. As a large systemic molecule, albumin can only cross the blood–brain barrier when this
barricade is compromised. The present data are thus indicative of increasing blood–brain barrier collapse and subsequent development of cerebral
edema. Coronal brain sections were obtained from sham animals and 24 hours after burn trauma, respectively, and were immunostained for (b) the
C5a receptor (C5aR) and (c) the C5a-like receptor 2 (C5L2). Sections were then counterstained with Fast Blue. Areas depicted focus on the
hippocampal area of the brain. Stained cells represent microglia. While there was no difference in the expression of C5aR between sham and burn
rats, C5L2 expression was significantly upregulated in brains harvested from burnt animals in comparison with sham littermates. The complement
system may play an important role in the development of burn-induced neuroinflammation. Slides were analyzed by light microscopy using fourfold
(4x) and 40-fold (40x) magnification.the expression of C5aR and C5L2 in the hippocampal areas
of sham or burn animals (Flierl MA, Stahel PF, Touban BM,
unpublished observations; Figure 1). While there seemed to
be no change in the hippocampal expression of C5aR
following burns, a significant upregulation of C5L2 was found
24 hours after burn trauma (Figure 1b,c). Contrary to earlier
speculation, C5L2 has been recently identified as a functional
receptor with a clearly proinflammatory role [24]. C5L2 may
therefore contribute to the complement-mediated neuro-
inflammation after burns.
Cytokines and chemokines
Severe burn trauma induces rapid local production of pro-
inflammatory cytokines by the affected tissues. Serum levels
of TNFα, IL-1β and IL-6 have all been reported to be elevated
following severe burn trauma in humans and animals [25-28].
While serum concentrations of IL-6, IL-8 and IL-1β correlate
proportionally with the extent of the severe burn trauma, only
serum IL-8 levels correlated positively with mortality [27,29].
TNFα, IL-1β and IL-6 have all been demonstrated to directly
induce a disruption of the BBB in vitro [30].
Recent studies in various animal models of neuroinflammation
have confirmed breakdown of the BBB in a cytokine/
chemokine-dependent manner [31-33]. Cytokines and
chemokines are initially only produced at the burn site, but
may become systemic and directly attack the BBB. In
addition, severe burn injury significantly upregulates mRNA
levels of TNFα, IL-1β and intercellular adhesion molecule 1 in
brain tissue as early as 3 hours post injury [26]. It is therefore
important to recognize that severe burn trauma exposes the
BBB to harmful proinflammatory mediators deriving from two
different compartments: the brain and the systemic circu-
lation. While, to date, there are no data available indicating
what severity of burn injury is required to produce breakdown
of the BBB in humans, most animal models cause severe
burns on 60 to 70% of the body surface to induce BBB
dysfunction [34,35].
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Figure 2
Pathophysiological events resulting in blood–brain barrier breakdown and development of cerebral edema following burn injury. Following major
burn trauma, a robust systemic inflammatory response is triggered. Proinflammatory mediators are produced by various immune cells, resulting in
breakdown of the blood–brain barrier, with subsequent activation of resident central nervous system cells, such as microglia and astrocytes, which
respond with further production of inflammatory markers, cumulating in a massive neuroinflammatory response and subsequent life-threatening
cerebral edema. In parallel, significant hormonal changes are triggered, resulting in a severe hypermetabolic state. CRF, corticotropin-releasing
factor; ACTH, adrenocorticotropic hormone.Nitric oxide
Nitric oxide (NO) has multifaceted biological and immuno-
logical functions [36,37] and is biosynthesized by different
isoforms of NO synthases localized in neurons, in endothelial
cells, or in mitochondria [38]. In contrast, inducible NO
synthase is expressed in all nucleated cells that generate
large bursts of NO in response to immunological stimuli [39].
NO output by inducible NO synthase is generally associated
with inflammatory conditions, such as hemorrhage, trauma,
or severe burns [39,40]. Inhibition of inducible NO synthase
reduces microvascular leakage after experimental severe
burn trauma [41], and beneficial effects of inducible NO
synthase blockade following severe burns have been
reported [42].
There is considerable debate about whether plasma of
urinary levels of nitrate and nitrite bear any predictive value
influencing clinical decision-making in burn patients. While
some studies report elevated levels of NO, nitrite, and nitrate
and correlate NO levels on day 5 post burn with mortality
[43-45], other studies describe significantly depressed
plasmatic nitrite levels and elevated nitrate levels [46].
Reports about urinary nitrite and nitrate concentrations
following burns also remain controversial [45-48]. The
adverse effects of NO following severe burns may be
mediated by interaction of NO with superoxide (O2
–),
resulting in formation of the highly toxic oxidant peroxynitrite
[49]. Peroxynitrite then causes extensive tissue damage and
edema formation [50,51]. Production of peroxynitrite has
been described in organs remote to the site of severe burn
injury, making it an important mediator of severe burn-induced
multiple organ failure [52,53].
Unexpectedly, mRNA expression of inducible NO synthase in
the hypothalamus is significantly decreased following thermal
injury [54], and NO levels rapidly declined in the cerebral
cortex following severe burns [55]. Hypotheses for this
central/peripheral discrepancy include recruitment of NO
from the brain towards the burn site, and/or a negative
feedback loop blocking central NO because of its oxidative
and free-radical deleterious effects [55].
Prostaglandin E2 and matrix metalloproteinases
Peripheral severe burn injury induces cyclooxygenase-2 as
well as microsomal-type prostaglandin E synthase in endo-
thelial cells of the central nervous system, resulting in
elevated levels of prostaglandin E2 in the cerebrospinal fluid
[56]. Elevation of prostaglandin E2 levels in cerebrospinal
fluids may therefore be involved in the pathogenesis of the
central nervous system-mediated systemic reactions follow-
ing severe burns. Ultimately, severe burn patients may benefit
from administration of a cyclooxygenase-2-selective inhibitor
in the treatment of central nervous system-mediated symp-
toms. Awareness of the increased risk of gastrointestinal
bleeding following administration of cyclooxygenase-2-selec-
tive inhibitors, however, is important.
Matrix metalloproteinases have been recently identified as key
players in the development of BBB dysfunction following
severe burn injury [34,35]. When upregulated following
severe burns, these proteases may contribute to the
degradation and destruction of the basal lamina of the BBB.
Disturbance of hormonal stress response
Following severe burn injury, the body reacts with a general
stress response [57]. After an initial ebb phase [12,58], a
universal hypercatabolism occurs [57]. This hypermetabolism
is, at least in part, mediated by catecholamines and correlates
with the severity of injury [14]. Following severe burn, plasma
catecholamines increase as much as 10-fold [59,60],
resulting in hyperdynamic circulation [61]. In addition, levels
of norepinephrine and dopamine increase in certain areas of
the brain [12,58,62] and increased levels of catecholamines
mobilize substrates from the body’s fat and protein stores,
leading to loss of lean body mass and muscular wasting [12].
Blockade of β-adrenergic receptors following severe burns
therefore decreases thermogenesis, tachycardia, cardiac
workload, and resting energy expenditure [63-65]. In severely
burned children, treatment with the β-adrenoceptor blocker
propranolol attenuated hypermetabolism and reversed
muscle-protein catabolism [66,67].
Alterations in hypothalamic function due to severe burns have
also been described [68]. More recent research confirmed
disturbance of the hypothalamic–pituitary–adrenal axis in
severely burned patients. Hypothalamic peptides and
receptors of the corticotropin releasing factor family have
been identified as putative mediators of severe burn-induced
hypermetabolism [69,70]. Serum prolactin has been found to
correlate with burn severity [29] and, further downstream,
temporary adrenal insufficiency has been reported in the early
stages of severe burn trauma [71], which was associated
with higher mortality rates [72]. A study investigating the
hypothalamic–pituitary–adrenal axis following thermal injury in
children found a disrupted adrenocorticotropic hormone–
adrenal feedback loop [73].
Cellular changes
Neurons
There are no reports to date directly investigating the
activation of microglia and glial scarring following severe
burns. In a recent study, the peripheral axon caliber and the
conduction velocity were severely impaired after experimental
severe burn injury [74]. These morphological and functional
deficits were observed at sides remote from the burn site.
Axon caliber reduction and reduced neuronal conduction
velocity following severe burns may therefore affect not only
peripheral, but also central, neurons and may contribute to
alterations of neuromuscular transmission and the develop-
ment of limb and respiratory muscle weakness that often
accompanies severe burns. Moreover, in burn-injured tissue,
long-lasting activation of peripheral sensory neurons results in
reorganization in the spinal cord [75]. Histologically, the
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μ-opioid receptors [76].
Nerve growth factor was detected recently in newly formed
epithelial cells at wound edges [77]. This growth factor may
not only assist in wound reorganization and healing, but may
also trigger hypersensitivity to heat and mechanical stimuli
following severe burns [78,79]. Nerve growth factor seems to
increase the strength and distribution of afferent neuronal
connections with the neurons of the dorsal horn [80], and
thereby expands their receptive fields [81]. These findings
indicate that central plasticity occurs in the spinal cord after
peripheral severe burns.
Neutrophils and macrophages
Severe burn injuries activate neutrophils and macrophages
[82]. Intracerebrally produced cytokines and chemokines
chemoattract phagocytes via the BBB [26]. In addition, once
the BBB is severely compromised, systemic phagocytes can
enter freely into the brain perivascular space [83]. Activated
phagocytes release their full inflammatory arsenal of proteases,
reactive oxygen species, and reactive nitrogen species
[84-86], exacerbating the neuroinflammatory response. The
productive capacity of phagocytes for proinflammatory
mediators is markedly enhanced following severe burns [82].
Macrophages display increased oxidative metabolism after
thermal injury [85], and patients with severe burns demon-
strate evidence of increased oxygen free radical activity [87].
Consequently, nonsurvivors of severe burn trauma display
increased consumption of antioxidants when compared with
survivors [87].
Neuropsychiatric effects and cognitive
dysfunction
Neuropsychiatric effects
Severe burn trauma triggers significant electroencephalo-
gram aberrations [88]. During initial cardiovascular stabiliza-
tion, resuscitation, and pain relief, less obvious neuro-
psychiatric consequences may be frequently masked by
sedative treatments. Neuroses, cognitive impairment, and
behavioral consequences have all been described in the
literature after severe burns [89,90]. During the initial phase
after thermal injury, temporary amnesia may occur [91].
As mentioned above, NO levels are upregulated throughout
the periphery following severe burn injury. In addition, NO has
been shown to be an important biomolecule in the central
nervous system, where neuronal NO synthases are widely
present [92]. The putative role of NO as a neuropsychiatric
neurotransmitter concerns long-term potentiation in the
hippocampus and long-term depression in the cerebellum
[93,94]. NO seems to be particularly involved in short-term
memory and learning [92,95]. Biobehavioral tests confirmed
the important role of NO in the acquisition and consolidation
of memories [96,97]. Rapid and significant decreases of
cerebral NO levels were recently found to account for the
behavioral changes occurring in rats [55]. It remains to be
seen whether alterations of intracerebral NO metabolism may
alleviate severe burn-induced cognitive impairment.
Cognitive dysfunction
Approximately one-third of burn victims show evidence of
physical, psychiatric, or alcohol-related problems, predis-
posing them to injury [98]. During the critical resuscitative
stage immediately following burn injury, patients frequently
display cognitive changes such as extreme drowsiness,
confusion, disorientation, delirium, and psychotic reactions
[99]. During the acute phase of recovery and restorative care,
symptoms of depression, anxiety, sleep disturbance, and
premorbid psychopathology are common [100]. Following
discharge, patients may develop symptoms of depression or
post-traumatic stress disorder, which can develop anywhere
from 1 month after burn trauma to 2 years after the initial burn
[99,101]. More than 50% of patients with burn injuries report
moderate to severe depression symptoms early in their
hospitalizations, and almost 50% retain these symptoms
2 years after injury [102,103]. Interestingly, the extent of burn
trauma does not predict the psychologic problems after burn
trauma [102-104]. One year after burn trauma, approximately
20% of patients meet the diagnostic criteria for post-
traumatic stress disorder [105].
Dysfunctional beliefs such as fear-avoidance or neuroticism
have been described as long-term sequelae after burn trauma
[106]. Sleep disorders have also been described as long-
term sequelae of burn trauma [107]. A multidisciplinary team
approach seems to be key to a successful management and
long-term reintegration of the burn patient.
Impact of the immunopathophysiology on
burn management
Advances in burn care have resulted in significant reduction
of mortality rates over the past 50 years [108-110]. In
particular, early and aggressive excision of the burn wound
has had the greatest impact on burn patient morbidity and
mortality by reducing the incidence of wound sepsis, hyper-
catabolism, numbers of operations, and hospital lengths of
stay [111-114]. The current treatment guidelines therefore
recommend routine and aggressive debridement of severe
burn wounds at the first medical facility available [115]. Even
during infectious complications following severe burns, the
cornerstone of treatment remains early, aggressive, and
definitive surgical debridement – while antibiotics are only
considered important adjuncts to management [116].
Subsequent skin grafting is usually achieved with autologous
or allogenic skin or biosynthetic dermal substitutes [117].
It is conceivable that the unquestionable benefit of early and
aggressive excision of the burn wound is closely related to
the pathophysiological changes described above. When the
burn load is excessive, the local inflammatory response
initiated by the injured peripheral tissues can spill over into
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inflammatory vicious cycle. The ensuing downward spiral may
thus be disrupted early by aggressive initial debridement and
may significantly reduce the systemic inflammatory burden
with improved end-organ function and reduced morbidity and
mortality. Early excision of full thickness burns is also
associated with attenuation of burn-induced hypermetabolism
[118-120].
Currently, bench-to-bedside transfer of several promising
immunomodulatory treatment strategies – such as immuno-
nutrition, administration of recombinant human activated
protein C, or topical immunosupressants – are under investi-
gation, as discussed in detail elsewhere [121]. As a result, a
recent report called for further translation of ‘excellent animal
work into the human arena’ to advance care of the severely
burnt patient [122].
Conclusion
Severe burn-induced neuroinflammation is a highly complex
and intricate entity. Optimal management of the severely
burned patient can only be achieved if the treating critical-
care personnel are intimately familiar with the systemic and
cerebral pathophysiology following severe burn trauma, and
adjust their treatment modalities accordingly. While collapse
of barriers in the lungs, kidneys, or liver is usually recognized
by simple laboratory parameters and is treated as part of the
severe burn management, burn-induced neuroinflammation
evolves over time and thus cannot be detected on initial
computerized tomography imaging evaluation. If the treating
physician fails to appreciate the complex cerebral
inflammatory events following burns, the patient may be
cleared prematurely for surgical interventions, which can
result in a potentially detrimental iatrogenic second hit. The
treating physician therefore needs to maintain a high index of
suspicion for this challenging entity. While some of the
molecular events involved are well understood, many
unanswered questions remain, which need to be addressed
in experimental and clinical studies in order to advance care
of the critically ill burn patient.
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